| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,699 |
3,877 |
$138K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,638 |
1,434 |
$71K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
476 |
379 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
601 |
250 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
38 |
36 |
$4K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
82 |
73 |
$4K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$1K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
15 |
15 |
$707.93 |
| 90756 |
|
18 |
14 |
$92.07 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
12 |
12 |
$27.74 |
| 3079F |
|
848 |
734 |
$10.00 |
| 3075F |
|
314 |
267 |
$10.00 |
| 3008F |
|
1,104 |
976 |
$0.00 |
| 1126F |
|
2,809 |
2,387 |
$0.00 |
| 1036F |
|
3,096 |
2,446 |
$0.00 |
| 3074F |
|
2,737 |
2,305 |
$0.00 |
| 1125F |
|
645 |
555 |
$0.00 |
| 3080F |
|
123 |
102 |
$0.00 |
| 1034F |
|
125 |
95 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
16 |
14 |
$0.00 |
| 1159F |
|
629 |
554 |
$0.00 |
| 3078F |
|
2,421 |
2,057 |
$0.00 |
| 3725F |
|
335 |
307 |
$0.00 |
| 3077F |
|
174 |
152 |
$0.00 |
| 1160F |
|
629 |
554 |
$0.00 |